JP Morgan Chase’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-11
| Closed | – | – | 6281 |
|
|
2018
Q4 | $0 | Buy |
+11
| New | +$7 | ﹤0.01% | 6165 |
|
|
2018
Q1 | – | Sell |
-100
| Closed | – | – | 5833 |
|
|
2017
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 5748 |
|
|
2017
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 5415 |
|
|
2017
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 5498 |
|
|
2017
Q1 | $0 | Buy |
+100
| New | +$314 | ﹤0.01% | 5430 |
|
|
2016
Q2 | – | Sell |
-432
| Closed | -$5K | – | 5154 |
|
|
2016
Q1 | $5K | Buy |
432
+374
| +645% | +$7.43K | ﹤0.01% | 4389 |
|
|
2015
Q4 | $2K | Buy |
+58
| New | +$1.75K | ﹤0.01% | 4559 |
|
|
2015
Q3 | – | Sell |
-2,674
| Closed | -$158K | – | 4239 |
|
|
2015
Q2 | $158K | Buy |
+2,674
| New | +$189K | ﹤0.01% | 3840 |
|
|
2013
Q4 | – | Sell |
-1,014
| Closed | -$28K | – | 4377 |
|
|
2013
Q3 | $28K | Buy |
+1,014
| New | +$32.6K | ﹤0.01% | 4298 |
|
JP Morgan Chase's PTX Position: Q1 2019 in Review
JP Morgan Chase sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 11 shares.
JP Morgan Chase first reported a position in PTX in Q3 2013 and held it in 9 quarters. The position peaked at $158K in Q2 2015. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.
- JP Morgan Chase reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
- JP Morgan Chase sold 11 Pernix Therapeutics Holdings, Inc. shares in Q1 2019.
- JP Morgan Chase first reported a position in Pernix Therapeutics Holdings, Inc. in Q3 2013 and held it in 9 quarters.
- JP Morgan Chase's Pernix Therapeutics Holdings, Inc. position peaked at $158K in Q2 2015.
- 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.